Imneskibart

N/A

Report date: 2025/11/10 17:55:24

Base Information

Drug NameImneskibart
Drug Alias NameBD-8AU-007BDG-8
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionT lymphocytes stimulantsInterleukin-2 inhibitors
TargetsInterleukin-2
Therapy Area/IndicationsSkin MelanomaSolid tumoursNeoplasm Metastasis +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiolojic Design Inc
China Registration ClassN/A

Develop Information

Active CompaniesAulos Bioscience Inc
Inactive CompaniesMonash Health
Active IndicationsSkin MelanomaSolid tumoursNeoplasm Metastasis +[4
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A